MiMedx Group Inc (MDXG) had a good day on the market for Monday December 10 as shares jumped 10.43% to close at $1.27. About 1.73 million shares traded hands on 995 trades for the day, compared with an average daily volume of 4.29 million shares out of a total float of 111.03 million. After opening the trading day at $1.17, shares of MiMedx Group Inc stayed within a range of $1.30 to $1.07.
With today’s gains, MiMedx Group Inc now has a market cap of $141.01 million.
The stock has a P/E Ratio of 3.7. Shares of MiMedx Group Inc have been trading within a range of $18.25 and $0.95 over the last year, and it had a 50-day SMA of $4.50 and a 200-day SMA of $5.72.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from human amniotic membrane and birth tissues and human skin and bone. Its products are primarily targeted toward the wound-care, surgical, sports medicine, and orthopedics markets. MiMedx’s key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. It also sells OrthoFlo, an allograft derived from amniotic fluid. In addition, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
MiMedx Group Inc is based out of Marietta, GA and has some 690 employees. Its CEO is David Coles.